Tirzepatide is the generic name for diabetes ... took the drug for nine months and had normal blood pressure or high blood pressure that was under control, and didn’t have type 2 diabetes.

Tirzepatide treatment was associated with reduced body weight and diabetes risk across 3 years among individuals with obesity and prediabetes.

Elon Musk has admitted to taking a weight-loss drug in a Christmas Day post on X, formerly Twitter, as he shared a picture of ...

“Today’s approval marks the first drug treatment option for certain patients with obstructive sleep apnea,” said Sally Seymour, M.D., director of the Division of Pulmonology, Allergy, and Critical ...

“It’s melting away.” Tirzepatide also reduced blood pressure and signs of inflammation. Those factors could help explain the benefits seen in heart failure patients, cardiologist Barry ...

Candidates for tirzepatide for weight loss have a BMI of at least 30, or a BMI of at least 27 with an underlying medical condition, like high cholesterol or high blood pressure. In this article ...

Novo Nordisk is finally facing some major competition to its obesity franchise juggernaut, now that Eli Lilly’s rival therapy tirzepatide ... such as high blood pressure, high cholesterol ...

Tirzepatide has been approved for treating ... or overweight and at least one weight-related condition, such as high blood pressure or high cholesterol. If you’re interested in learning more ...

Eli Lilly’s weight-loss drug tirzepatide has become the first drug for obstructive sleep apnea, a common but serious sleep ...

The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to cheaper versions could end.